Clinical Trial Update: Direct Pulp Capping Agent on Human Pulp Tissue [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a Direct Pulp Capping Agent in patients with reversible pulpitis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Reversible Pulpitis

Drugs mentioned

• Direct Pulp Capping Agent

Snippet

Sponsor: DR SURINDER SACHDEVA | Conditions: Reversible Pulpitis | Phase 4 | Status: RECRUITING